Compare Stocks: EOLS, HCM, TRLV, and PRGO

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EOLS Evolus	$8.88	$7.04	$3.86 ▼ $9.12	$586.53M	1.35	1.20 million shs	1.06 million shs
HCM HUTCHMED	$12.38 -0.2%	$11.50	$9.77 ▼ $18.30	$2.16B	0.23	62,925 shs	59,140 shs
PRGO Perrigo	$14.54 +1.2%	$11.48	$9.23 ▼ $23.95	$2.01B	0.51	2.85 million shs	2.60 million shs
TRLV Trulieve Cannabis	$11.88 +7.7%	$9.25	$4.62 ▼ $13.28	$2.28B	N/A	1.04 million shs	1.36 million shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EOLS Evolus	0.00%	+5.84%	+47.75%	+35.37%	+17.15%
HCM HUTCHMED	0.00%	-1.98%	+14.95%	+8.12%	-17.25%
PRGO Perrigo	0.00%	+2.25%	+40.31%	+31.83%	-39.20%
TRLV Trulieve Cannabis	0.00%	+7.80%	+40.58%	+1,187,999,900.00%	+1,187,999,900.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EOLS Evolus	$8.88	$7.04	$3.86 ▼ $9.12	$586.53M	1.35	1.20 million shs	1.06 million shs
HCM HUTCHMED	$12.38 -0.2%	$11.50	$9.77 ▼ $18.30	$2.16B	0.23	62,925 shs	59,140 shs
PRGO Perrigo	$14.54 +1.2%	$11.48	$9.23 ▼ $23.95	$2.01B	0.51	2.85 million shs	2.60 million shs
TRLV Trulieve Cannabis	$11.88 +7.7%	$9.25	$4.62 ▼ $13.28	$2.28B	N/A	1.04 million shs	1.36 million shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EOLS Evolus	0.00%	+5.84%	+47.75%	+35.37%	+17.15%
HCM HUTCHMED	0.00%	-1.98%	+14.95%	+8.12%	-17.25%
PRGO Perrigo	0.00%	+2.25%	+40.31%	+31.83%	-39.20%
TRLV Trulieve Cannabis	0.00%	+7.80%	+40.58%	+1,187,999,900.00%	+1,187,999,900.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EOLS Evolus	2.50	Moderate Buy	$14.50	63.29% Upside
HCM HUTCHMED	2.17	Hold	$14.87	20.09% Upside
PRGO Perrigo	2.00	Hold	$19.33	32.97% Upside
TRLV Trulieve Cannabis	2.00	Hold	$15.00	26.26% Upside

Current Analyst Ratings Breakdown

Latest EOLS, HCM, TRLV, and PRGO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/25/2026	EOLS Evolus	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$13.00
8/7/2026	TRLV Trulieve Cannabis	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$15.00
8/6/2026	PRGO Perrigo	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Sell (D)
7/31/2026	HCM HUTCHMED	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D)
7/23/2026	HCM HUTCHMED	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$16.00 ➝ $14.00
7/21/2026	PRGO Perrigo	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/20/2026	TRLV Trulieve Cannabis	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$15.00
7/17/2026	HCM HUTCHMED	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
7/7/2026	HCM HUTCHMED	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$20.00 ➝ $17.00
6/29/2026	HCM HUTCHMED	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
6/18/2026	TRLV Trulieve Cannabis	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold

(Data available from 8/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EOLS Evolus	$297.18M	1.97	N/A	N/A	($0.36) per share	-24.67
HCM HUTCHMED	$548.51M	3.94	$2.70 per share	4.59	$7.17 per share	1.73
PRGO Perrigo	$4.25B	0.47	$5.31 per share	2.74	$21.33 per share	0.68
TRLV Trulieve Cannabis	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EOLS Evolus	-$51.64M	-$0.52	N/A	111.00	N/A	-10.85%	N/A	-13.00%	11/4/2026 (Estimated)
HCM HUTCHMED	$456.91M	N/A	N/A	56.27	N/A	N/A	N/A	N/A	N/A
PRGO Perrigo	-$1.43B	-$12.51	N/A	6.16	1.66	-41.85%	11.25%	4.08%	11/4/2026 (Estimated)
TRLV Trulieve Cannabis	N/A	N/A	N/A	20.84	N/A	N/A	N/A	N/A	N/A

Latest EOLS, HCM, TRLV, and PRGO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2026	Q2 2026	TRLV Trulieve Cannabis	$0.06	$0.11	+$0.05	-$2.10	$268.82 million	$271.00 million
8/5/2026	Q2 2026	PRGO Perrigo	$0.3880	$0.50	+$0.1120	$0.53	$1.02 billion	$1.02 billion
7/30/2026	H1 2026	HCM HUTCHMED	$0.1450	$0.05	-$0.0950	$0.05	$304.16 million	$139.14 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
EOLS Evolus	N/A	N/A	N/A	N/A	N/A
HCM HUTCHMED	N/A	N/A	N/A	N/A	N/A
PRGO Perrigo	$1.16	7.98%	+5.21%	N/A	23 Years
TRLV Trulieve Cannabis	N/A	N/A	N/A	N/A	N/A

Latest EOLS, HCM, TRLV, and PRGO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/30/2026	PRGO Perrigo	quarterly	$0.29	7.98%	8/28/2026	8/28/2026	9/15/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EOLS Evolus	N/A	1.70	1.28
HCM HUTCHMED	0.06	5.64	5.50
PRGO Perrigo	1.31	2.32	1.32
TRLV Trulieve Cannabis	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EOLS Evolus	90.69%
HCM HUTCHMED	8.82%
PRGO Perrigo	95.91%
TRLV Trulieve Cannabis	N/A

Insider Ownership

Company	Insider Ownership
EOLS Evolus	5.00%
HCM HUTCHMED	3.60%
PRGO Perrigo	0.40%
TRLV Trulieve Cannabis	3.79%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EOLS Evolus	170	66.05 million	62.75 million	Optionable
HCM HUTCHMED	1,796	174.47 million	168.19 million	Not Optionable
PRGO Perrigo	8,100	138.77 million	138.21 million	Optionable
TRLV Trulieve Cannabis	5,000	192.57 million	185.27 million	N/A

EOLS, HCM, TRLV, and PRGO Headlines

Recent News About These Companies

Cannabis Stocks To Watch Now - August 29th

August 29 at 12:01 PM | marketbeat.com

Cannabis Stocks To Follow Now - August 26th

August 26, 2026 | marketbeat.com

Trulieve Cannabis (NYSE:TRLV) Stock Price Up 4.5% - Here's Why

August 26, 2026 | marketbeat.com

Trulieve to Ring The Closing Bell at the New York Stock Exchange as First U.S. Cannabis Company Listed on the NYSE

August 18, 2026 | prnewswire.com

Trulieve Cannabis (NYSE:TRLV) Trading Up 8.3% - Here's What Happened

August 13, 2026 | marketbeat.com

3 Marijuana Stocks For Investors To Consider

August 12, 2026 | marijuanastocks.comM

Trulieve Completes Redomicile from British Columbia to Delaware

August 11, 2026 | prnewswire.com

Trulieve Cannabis Q2 Earnings Call Highlights

August 9, 2026 | marketbeat.com

Trulieve Cannabis (TRLV) Reports Steeper Losses And Lower Sales, Is The Valuation Discount Justified?

August 8, 2026 | uk.finance.yahoo.com

Trulieve Cannabis (NYSE:TRLV) Cut to Hold at Wall Street Zen

August 8, 2026 | marketbeat.com

Trulieve Cannabis (NYSE:TRLV) Releases Earnings Results, Beats Estimates By $0.05 EPS

August 7, 2026 | marketbeat.com

Trulieve Cannabis (NYSE:TRLV) Update: Key Signals to Watch

August 7, 2026 | kalkinemedia.comK

Trulieve Cannabis Corp. 2026 Q2 - Results - Earnings Call Presentation

August 7, 2026 | seekingalpha.com

Trulieve Cannabis (NYSE:TRLV) Given Overweight Rating at Cantor Fitzgerald

August 7, 2026 | marketbeat.com

Trulieve: Q2 Earnings Snapshot

August 7, 2026 | chron.com

Trulieve Reports Second Quarter 2026 Results

August 7, 2026 | prnewswire.com

Der aktuelle Kurs der Trulieve Cannabis Corp Aktie beträgt 8,9600.

August 5, 2026 | de.investing.com

Trulieve Announces August 2026 Event Participation

August 5, 2026 | prnewswire.com

Trulieve to Open Medical Cannabis Dispensary in Marco Island, Florida

July 16, 2026 | prnewswire.com

Why Is Trulieve (NYSE:TRLV) Expanding Its NYSE Presence?

July 13, 2026 | kalkinemedia.comK

Two marijuana MSOs named among ‘America’s Best Companies’

July 10, 2026 | mjbizdaily.comM

New MarketBeat Followers Over Time

Media Sentiment Over Time

EOLS, HCM, TRLV, and PRGO Company Descriptions

Evolus NASDAQ:EOLS

$8.88 0.00 (0.00%)

As of 08/28/2026 04:00 PM Eastern

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

HUTCHMED NASDAQ:HCM

$12.38 -0.03 (-0.24%)

As of 08/28/2026 04:00 PM Eastern

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.

Perrigo NYSE:PRGO

$14.54 +0.17 (+1.18%)

As of 08/28/2026 03:58 PM Eastern

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Trulieve Cannabis NYSE:TRLV

$11.88 +0.85 (+7.71%)

As of 08/28/2026 03:58 PM Eastern

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. As of May 5, 2021, the company operated through 87 dispensaries in the United States. The company is headquartered in Quincy, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest EOLS, HCM, TRLV, and PRGO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest EOLS, HCM, TRLV, and PRGO Earnings

Compare Dividends

Latest EOLS, HCM, TRLV, and PRGO Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

EOLS, HCM, TRLV, and PRGO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

EOLS, HCM, TRLV, and PRGO Company Descriptions

Evolus NASDAQ:EOLS

HUTCHMED NASDAQ:HCM

Perrigo NYSE:PRGO

Trulieve Cannabis NYSE:TRLV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest EOLS, HCM, TRLV, and PRGO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest EOLS, HCM, TRLV, and PRGO Earnings

Compare Dividends

Latest EOLS, HCM, TRLV, and PRGO Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

EOLS, HCM, TRLV, and PRGO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

EOLS, HCM, TRLV, and PRGO Company Descriptions

Evolus NASDAQ:EOLS

HUTCHMED NASDAQ:HCM

Perrigo NYSE:PRGO

Trulieve Cannabis NYSE:TRLV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools